(Q39572319)

13 September 2017

1 reference

title

The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response (English)

1 reference

13 September 2017

0 references

J W Larrick

1

1 reference

13 September 2017

S L Kunkel

series ordinal

2

1 reference

13 September 2017

publication date

1 March 1988

1 reference

13 September 2017

published in

Pharmaceutical Research

1 reference

13 September 2017

volume

5

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

129-139

1 reference

13 September 2017

1 reference

12 December 2020

Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells

1 reference

12 December 2020

A urine inhibitor of interleukin 1 activity that blocks ligand binding.

1 reference

12 December 2020

An improved assay for the detection of interleukin 1.

1 reference

12 December 2020

The human LT system. XII. Purification and functional studies of LT and "TNF-like" LT forms from a continuous human T cell line.

1 reference

12 December 2020

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

1 reference

12 December 2020

Detection and characterization of high affinity plasma membrane receptors for human interleukin 1.

1 reference

12 December 2020

C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes.

1 reference

12 December 2020

Modulation of endothelial cell hemostatic properties by tumor necrosis factor

1 reference

12 December 2020

Bone Resorbing Activity in Supernatant Fluid from Cultured Human Peripheral Blood Leukocytes

1 reference

12 December 2020

Effect of tumor necrosis factor alpha on mitogen-activated human B cells

1 reference

12 December 2020

Antiviral effects of recombinant tumour necrosis factor in vitro

1 reference

12 December 2020

Two distinct factors are required for induction of T-cell growth

1 reference

12 December 2020

Purification and characterization of a unique human interleukin 1 from the tumor cell line U937.

1 reference

12 December 2020

Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon

1 reference

12 December 2020

An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism

1 reference

12 December 2020

Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin

1 reference

12 December 2020

Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

1 reference

12 December 2020

Interleukin 1-mediated induction of kappa-light chain synthesis and surface immunoglobulin expression on pre-B cells.

1 reference

12 December 2020

Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex

1 reference

12 December 2020

Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype

1 reference

12 December 2020

Recombinant tumor necrosis factor and interleukin-1 both stimulate human synovial cell arachidonic acid release and phospholipid metabolism

1 reference

12 December 2020

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

12 December 2020

Purification to homogeneity and NH2-terminal amino acid sequence of a novel interleukin 1 species derived from a human B cell line

1 reference

12 December 2020

Uromodulin, an immunosuppressive protein derived from pregnancy urine, is an inhibitor of interleukin 1.

1 reference

12 December 2020

The active form of tumor necrosis factor is a trimer

1 reference

12 December 2020

Human monoclonal antibodies that recognize conserved epitopes in the core-lipid A region of lipopolysaccharides

1 reference

12 December 2020

Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells.

1 reference

12 December 2020

Prostaglandin E2 and thromboxane B2 in cerebrospinal fluid of afebrile and febrile cat.

1 reference

12 December 2020

Human leukocytic pyrogen induces release of specific granule contents from human neutrophils

1 reference

12 December 2020

Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta.

1 reference

12 December 2020

Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor

1 reference

12 December 2020

Tumor necrosis factor increases the number of epidermal growth factor receptors on human fibroblasts

1 reference

12 December 2020

Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein.

1 reference

12 December 2020

Recombinant tumor necrosis factor causes activation of human granulocytes.

1 reference

12 December 2020

Lymphocyte in vitro Cytotoxicity: Lymphotoxins of Several Mammalian Species

1 reference

12 December 2020

Induction of a 26-kDa-protein mRNA in human cells treated with an interleukin-1-related, leukocyte-derived factor

1 reference

12 December 2020

Release of multiple hormones by a direct action of interleukin-1 on pituitary cells

1 reference

12 December 2020

Secretory products of macrophages

1 reference

12 December 2020

Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism

1 reference

12 December 2020

Potentiation of the T-lymphocyte response to mitogens. I. The responding cell

1 reference

12 December 2020

Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor

1 reference

12 December 2020

An update on human interleukin-1: from molecular biology to clinical relevance

1 reference

12 December 2020

The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors

1 reference

12 December 2020

Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor

1 reference

12 December 2020

Interleukin 1 can act as a B-cell growth and differentiation factor

1 reference

12 December 2020

Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in mice.

1 reference

12 December 2020

Induction of human interleukin 1 mRNA measured by collagenase- and prostaglandin E2-stimulating activity in rheumatoid synovial cells

1 reference

12 December 2020

Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular endothelial cells

1 reference

12 December 2020

Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines

1 reference

12 December 2020

The role of macrophages in the acute-phase response: SAA inducer is closely related to lymphocyte activating factor and endogenous pyrogen

1 reference

12 December 2020

The effect of temperature on the activation of thymocytes by interleukins I and II.

1 reference

12 December 2020

Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).

1 reference

12 December 2020

Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage

1 reference

12 December 2020

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

1 reference

12 December 2020

Acute in vivo effects of human recombinant tumor necrosis factor

1 reference

12 December 2020

Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1.

1 reference

12 December 2020

Characterization of murine monoclonal antibodies that recognize neutralizing epitopes on human C5a.

1 reference

12 December 2020

Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors

1 reference

12 December 2020

Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon

1 reference

12 December 2020

Fever and immunoregulation: hyperthermia, interleukins 1 and 2, and T-cell proliferation

1 reference

12 December 2020

Tumor necrosis factor provokes superoxide anion generation from neutrophils

1 reference

12 December 2020

Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity

1 reference

12 December 2020

A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia

1 reference

12 December 2020

Stimulation of B cell growth and differentiation by murine recombinant interleukin 1

1 reference

12 December 2020

Recombinant gamma interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients

1 reference

12 December 2020

Tumor necrosis factor inhibits MYC expression in HL-60 cells at the level of mRNA transcription

1 reference

12 December 2020

Induction of interleukin 2 receptor (TAC) by tumor necrosis factor in YT cells

1 reference

12 December 2020

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

1 reference

12 December 2020

Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma

1 reference

12 December 2020

Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis

1 reference

12 December 2020

Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells.

1 reference

12 December 2020

Further comparisons of endogenous pyrogens and leukocytic endogenous mediators

1 reference

12 December 2020

Protective effects of thromboxane synthetase inhibitors in rats in endotoxic shock

1 reference

12 December 2020

Inhibition of interleukin 1 activity by a factor in submandibular glands of rats

1 reference

12 December 2020

Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line

1 reference

12 December 2020

Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities

1 reference

12 December 2020

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

1 reference

12 December 2020

Murine monoclonal antibodies defining neutralizing epitopes on tumor necrosis factor

1 reference

12 December 2020

Secretory products of macrophages and their physiological functions

1 reference

12 December 2020

Substance P and immunoregulation

1 reference

12 December 2020

Purification to homogeneity and amino acid sequence analysis of two anionic species of human interleukin 1.

1 reference

12 December 2020

Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies

1 reference

12 December 2020

Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes.

1 reference

12 December 2020

Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition

1 reference

12 December 2020

Membrane-associated IL 1-like activity on rat dendritic cells

1 reference

12 December 2020

A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity

1 reference

12 December 2020

T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation

1 reference

12 December 2020

Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes.

1 reference

12 December 2020

Cloning and expression of murine interleukin-1 cDNA in Escherichia coli

1 reference

12 December 2020

Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/kinase

1 reference

12 December 2020

Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor

1 reference

12 December 2020

Identification of human uromodulin as the Tamm-Horsfall urinary glycoprotein

1 reference

12 December 2020

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

12 December 2020

The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system

1 reference

12 December 2020

Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor

1 reference

12 December 2020

Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.

1 reference

12 December 2020

Cachectin and tumour necrosis factor as two sides of the same biological coin

1 reference

12 December 2020

Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors

1 reference

12 December 2020

The four biochemically distinct species of human interleukin 1 all exhibit similar biologic activities

1 reference

12 December 2020

Regulation of lipoprotein lipase synthesis and 3T3-L1 adipocyte metabolism by recombinant interleukin 1.

1 reference

12 December 2020

Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2.

1 reference

12 December 2020

In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta

1 reference

12 December 2020

Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.

1 reference

12 December 2020

Studies of an interleukin 1 inhibitor: characterization and clinical significance.

1 reference

12 December 2020

Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae

1 reference

12 December 2020

Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro

1 reference

12 December 2020

Neutrophil release after injections of endotoxin or leukocytic endogenous mediator into rats

1 reference

12 December 2020

Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells

1 reference

12 December 2020

Stimulatory effect of hr tumor necrosis factor on TxB2 release by polymorphonuclears and macrophages

1 reference

12 December 2020

Tumor necrosis factors: gene structure and biological activities

1 reference

12 December 2020

Interleukin 1 regulates human metallothionein gene expression

1 reference

12 December 2020

Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta

1 reference

12 December 2020

Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity

1 reference

12 December 2020

Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons

1 reference

12 December 2020

Molecular cloning of the complementary DNA for human tumor necrosis factor

1 reference

12 December 2020

Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

1 reference

12 December 2020

Normal human neutrophils are a source of a specific interleukin 1 inhibitor

1 reference

12 December 2020

Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts

1 reference

12 December 2020

Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor

1 reference

12 December 2020

Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta 2 interferon involved

1 reference

12 December 2020

Prostaglandins as endogenous mediators of interleukin 1 production

1 reference

12 December 2020

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

1 reference

12 December 2020

Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20)

1 reference

12 December 2020

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

1 reference

12 December 2020

Interleukin 1: a common endogenous mediator of inflammation and the local Shwartzman reaction

1 reference

12 December 2020

Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.

1 reference

12 December 2020

Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.

1 reference

12 December 2020

C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma

1 reference

12 December 2020

Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1

1 reference

12 December 2020

The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma

1 reference

12 December 2020

Recombinant human interleukin 1 alpha: purification and biological characterization.

1 reference

12 December 2020

Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor

1 reference

12 December 2020

1 reference

12 December 2020

Effects of human interleukin 1 and human tumor necrosis factor on human T lymphocyte colony formation

1 reference

12 December 2020

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

1 reference

12 December 2020

Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells

1 reference

12 December 2020

Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity

1 reference

12 December 2020

Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters

1 reference

12 December 2020

Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1

1 reference

12 December 2020

Spontaneous production of fibroblast-activating factor(s) by synovial inflammatory cells. A potential mechanism for enhanced tissue destruction

1 reference

12 December 2020

Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1015904721223

1 reference

13 September 2017

1 reference